BioDeeptech Intelligence v2.4 ยท Global
5 DB LIVE
โœจ Precision Bio Intelligence for Medical Researchers & VC Analysts Save $3,000/yr DB Subscriptions

Stop Scraping PubMed All Night.
Instant 16:9 Multi-Omics Decks in Seconds.

Cross-validated across 5 global databases (Open Targets, PubMed, UniProt, ChEMBL, ClinicalTrials.gov).
Get prioritized target scores, mechanism trends, and clinical pipeline due diligence for just $10 per 3-in-1 Suite.

๐Ÿงฌ Target Confidence Radar: APP vs PSEN1 (MONDO_0004975)
LIVE SYNCED
APP amyloid beta precursor
0.872 Score
Literature Evidence
0.997
Clinical Validation
0.977
Genetic Association
0.923
PSEN1 presenilin 1
0.867 Score
Genetic Literature
0.888
Clinical Validation
0.977
Literature Support
0.994
๐Ÿ’ก Complete target pipelines across 5 diseases available in 16:9 executive presentation decks.
Multi-Disease Target Intelligence

Alzheimer's Disease Target Matrix

Prioritized multi-dimensional validation scores from Open Targets Platform official records.

Rank Target Symbol Approved Name Overall Score Literature Evidence Clinical Phase Dossier
Commercial Intelligence Store

Verified Multi-Omics Target Research Suites

Institution-grade multi-omics target dossiers. 12+ Free Lead Magnets ($0) & High-Impact Commercial Suites ($10.00 each).

๐Ÿ“„

9-Page A4 Whitepaper

Nature/McKinsey-grade publication dossier for academic submission & printing.

๐Ÿ“Š

16:9 Presentation Deck

Ready-to-present executive slide deck for seminar & lab meeting decks.

๐Ÿ“‘

Raw Multi-Omics CSV/JSON

Full target scores, Ensembl IDs, and clinical trial matrices for Python/Excel.

๐Ÿ“œ

Patent & TAM Market Maps

Composition-of-matter expiry (2026-2038) & 2033 TAM projections.

๐Ÿ”
Showing 12 of 87 Validated Pipelines All Target Pipelines
๐ŸŽ Free Lead Magnet ($0) FREE / $0
Alzheimer 3D Render
Alzheimer's 3-in-1 Research Suite
APP ยท PSEN1 ยท TREM2 9-Page Full Suite

Alzheimer's Multi-Omics Research Suite

9-page comprehensive dossier: Multi-omics genetic scoring, 3D structural pockets, patent expiry timeline, and global market projections.

  • โœ“ 9-Page A4 Research Whitepaper (PDF)
  • โœ“ 16:9 Presentation Slides & Raw Dataset (CSV/JSON/ZIP)
๐Ÿ“ฅ Download Free 3-in-1 Suite ($0)
Instant Download $10.00 / 3-in-1 Suite
Parkinson 3D Render
Parkinson's Research Suite
SNCA ยท LRRK2 ยท PRKN 9-Page A4 + Data

Parkinson's Alpha-Synuclein & LRRK2 Suite

SNCA propagation, LRRK2 Rab phosphorylation dynamics, GCase allosteric chaperones, and clinical neuroprotection pipeline due diligence.

  • โœ“ 9-Page A4 Research Whitepaper & Due Diligence Matrix
  • โœ“ 3D Pockets, Patent Expiry Map & Raw CSV/JSON Dataset
Instant Download $10.00 / 3-in-1 Suite
Pancreatic Cancer 3D Render
Pancreatic Cancer Suite
KRAS ยท TP53 ยท SMAD4 9-Page A4 + Data

Pancreatic Cancer KRAS Inhibitors Suite

Non-covalent KRAS G12D/V switch-II binders, FAK/TGF-ฮฒ stroma remodeling, and personalized mRNA neoantigen vaccine combinations.

  • โœ“ 9-Page A4 Research Whitepaper & Due Diligence Matrix
  • โœ“ 3D Pockets, Patent Expiry Map & Raw CSV/JSON Dataset
Instant Download $10.00 / 3-in-1 Suite
Glioblastoma 3D Render
Glioblastoma Research Suite
EGFRvIII ยท PTEN ยท IDH1 9-Page A4 + Data

Glioblastoma BBB Penetration & RMT Suite

EGFRvIII truncated kinase signaling, TfR receptor-mediated transcytosis (RMT), IDH1 2-HG inhibitors, and dual-target locoregional CAR-T.

  • โœ“ 9-Page A4 Research Whitepaper & Due Diligence Matrix
  • โœ“ 3D Pockets, Patent Expiry Map & Raw CSV/JSON Dataset
Instant Download $10.00 / 3-in-1 Suite
NSCLC Lung Cancer 3D Render
NSCLC Precision Oncology Suite
4th Gen TKI ยท TROP2 ADC 9-Page A4 + Data

NSCLC 4th-Gen TKI & Next-Gen ADC Suite

C797S triple-mutation resistance breakers, MET bypass pathways, and TROP2/HER3 ADC combination trial pipelines.

  • โœ“ 9-Page A4 Research Whitepaper & Due Diligence Matrix
  • โœ“ 3D Pockets, Patent Expiry Map & Raw CSV/JSON Dataset
Executive 16:9 Deck Reader

Alzheimer's Disease Target Report Preview

Slide 1 of 3
PART 1 ยท CORE GENETIC TARGETS

Alzheimer's Disease: Core Target Genes

TARGET #1

APP (Amyloid Beta Precursor)

Open Targets Association Score: 0.872. Fundamental driver of amyloid-beta plaque deposition with 0.99 literature and clinical validation.

TARGET #2

PSEN1 (Presenilin 1)

Association Score: 0.867. Catalytic subunit of gamma-secretase complex and primary genetic determinant of familial early-onset Alzheimer's.

TAKEAWAY

Therapeutic Mainstream Strategy

Modulating or inhibiting mutations and cleaved byproducts of these two genes remains the primary backbone of global clinical pipelines.

Data Source: Open Targets Platform (5 DB Live) Page 1 / 3 (Free Preview Available)
PART 2 ยท LITERATURE INSIGHTS

Recent Research Trends (PubMed NLP Summary)

TREND #1

APP Transcriptional Control & Cellular Senescence

Rapid surge in investigations linking microglial senescence pathways directly with APP expression modulation beyond simple amyloid clearance.

TREND #2

Tau Dysfunction Synergy Mechanisms

Targeting molecular axes where APP fragments accelerate tauopathy has emerged as a cornerstone for next-generation combination therapies.

PubMed Synthesis

Multi-Mechanism Targeting

Combining neuro-inflammation regulation with proteostasis restoration is gaining significant traction to surpass single-antibody limits.

Data Source: NCBI PubMed E-Utilities NLP Pipeline Page 2 / 3
PART 3 ยท INVESTMENT & CLINICAL STRATEGY

Investment / Clinical Strategy Insights

Pipeline Landscape

APP / PSEN1 Competitive Density

High big-pharma density on validated targets creates premium valuation upside for biotech platforms with proprietary BBB-crossing delivery systems.

Emerging Axes

Dual Targeting: Senescence & Microglia

Early-stage investment opportunities favor startups restoring immune homeostasis alongside classic amyloid suppression.

VC Checklist

5-DB Score Filtering

Utilize genomic target concordance (Score > 0.8) across global databases as a primary due diligence filter before term-sheet issuance.

BioDeeptech Proprietary Intelligence Analysis Page 3 / 3 (Full Report Available)
Active Pipeline ยท Complete Research Suite ๐Ÿ”’ 256-Bit SSL Encrypted ยท Instant ZIP Download

Everything Included in This Target Dossier Suite

Commercial-grade institutional intelligence designed for Biotech VC due diligence, target validation, and clinical pipeline benchmarking.

๐Ÿ“„
A4 Archival Whitepaper

9-Page Executive Dossier (PDF)

Comprehensive target prioritization scores, clinical trial pipeline landscape, and molecular mechanism breakdown.

  • โœ“ Multi-omics association scoring (0.00 - 1.00)
  • โœ“ Small-molecule & biologic tractability metrics
  • โœ“ Lipinski Rule-of-5 & BBB penetration indices
  • โœ“ Clinical phase breakdown (Phase I - III)
๐Ÿ“Š
Presentation Asset

16:9 Multi-Omics Slide Deck

Full presentation-ready slide deck formatted for investment committees, board reviews, and lab meetings.

  • โœ“ High-resolution vectors & clean typography
  • โœ“ PubMed NLP literature trend synthesis
  • โœ“ Prioritized genetic driver pathways
  • โœ“ Institutional VC investment checklist
๐Ÿ’พ
Machine-Readable Data

Raw Target Tables (CSV & JSON)

Standardized raw data tables ready for immediate ingestion into Python, R, pandas, Excel, or SQL databases.

  • โœ“ 15+ prioritized targets with Ensembl/UniProt IDs
  • โœ“ Raw clinical stages, literature counts & flags
  • โœ“ Full commercial & academic reuse rights
  • โœ“ Pure open formats with zero vendor lock-in
$10.00
USD ยท One-Time Purchase Save $3,000+ vs. enterprise database subscriptions

Instant ZIP download containing all 3 deliverables + official email receipt & invoice.

๐Ÿ›ก๏ธ 5-DB Verified โšก Instant Download ๐Ÿค 30-Day Guarantee
โ“ How is the 3-in-1 Suite delivered?
Immediately upon clicking or checking out, your browser will automatically download the consolidated ZIP package containing the 9-Page PDF, Slide Deck, and raw CSV/JSON data files.
โ“ Can I use this for investor decks & publications?
Yes. Your purchase grants you a full commercial and academic presentation license with zero royalties or attribution required.
Methodology & Data Pipeline

5-Global Database Cross-Validation Engine

Every target association is systematically cross-referenced across authoritative worldwide bio repositories.

๐Ÿงฌ

Open Targets Platform

EMBL-EBI & Sanger Institute

GraphQL API Integration
โ†’
๐Ÿ“š

NCBI PubMed

National Library of Medicine

E-utilities NLP Pipeline
โ†’
โšก

Gemini LLM Synthesizer

Multi-Omics Synthesis & 16:9 Structuring

Prompt Engine v2.4
โ†’
๐Ÿ“„

Chrome Headless PDF

1920x1080 Vector Rendering

100% Lossless Deck
๐Ÿงฌ BioDeeptech Intelligence collective by Cravveo

Accelerating Global Drug Discovery with Zero-Friction Multi-Omics

We empower biopharma researchers, biotech founders, and venture capital analysts with institution-grade target due diligence dossiers for $10, eliminating the need for bloated $3,000/year subscriptions.

๐Ÿ”ฌ

5-Database Cross Validation

Every target association score is algorithmically cross-verified across Open Targets, NCBI PubMed, UniProt, ChEMBL, and ClinicalTrials.gov to guarantee 100% scientific reproducibility.

โšก

Instant $10 Accessibility

No recurring lock-in contracts or enterprise price gouging. Pay $10 per complete disease suite with lifetime access, free lead magnets, and instant delivery.

๐Ÿ“ฆ

Production 3-in-1 Suite

Delivered with a 9-Page A4 Research Whitepaper (PDF), an executive 16:9 Presentation Deck (HTML/PDF), and raw Multi-Omics CSV/JSON datasets.

โ“ Frequently Asked Questions

Q: What is included in the $10 single purchase?

You receive the complete 3-in-1 Suite: (1) Print-ready 9-Page A4 PDF whitepaper, (2) 16:9 widescreen presentation slide deck, and (3) Clean Multi-Omics CSV & JSON datasets with Ensembl IDs and clinical phases.

Q: Can I use these materials in VC memos and research papers?

Yes! All datasets and presentation slide decks come with full commercial and academic presentation rights. You can cite, present, and embed them in lab seminars, grant proposals, and investment memos.

Q: How do I restore my purchase if I change computers?

Click the [๐Ÿ”“ Already Purchased?] button in the top navigation and enter your checkout email address. You will also receive lifetime access via the official Polar.sh Customer Portal.

๐Ÿ“ฉ Direct Contact & Support

Direct to Inbox

Have a question, custom disease synthesis request, or institutional inquiry? Send a message directly without opening an email app:

ENSG00000142192

APP

amyloid beta precursor protein

0.87 Overall Score
This target possesses verified scientific association on Open Targets Platform.

Multi-Dimensional Score Breakdown